Sandra Duquesne
University of Freiburg(DE)University Medical Center Freiburg(DE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Acute Myeloid Leukemia Research, Immune cells in cancer, CAR-T cell therapy research
Most-Cited Works
- → Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells(2018)284 cited
- → Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms(2018)221 cited
- → Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation(2020)144 cited
- → Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset(2018)143 cited
- → Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans(2020)125 cited
- → miR-146a Controls Immune Response in the Melanoma Microenvironment(2018)100 cited
- → MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors(2020)81 cited
- → Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation(2022)52 cited
- → Amotl2a interacts with the Hippo effector Yap1 and the Wnt/β-catenin effector Lef1 to control tissue size in zebrafish(2015)47 cited
- → Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity(2025)35 cited